BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 32599009)

  • 1. Off-label use of pulmonary vasodilators after left ventricular assist device implantation: Calling in the evidence.
    Papathanasiou M; Ruhparwar A; Kamler M; Rassaf T; Luedike P
    Pharmacol Ther; 2020 Oct; 214():107619. PubMed ID: 32599009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Outcomes of Patients Treated With Pulmonary Vasodilators Early and in High Dose After Left Ventricular Assist Device Implantation.
    Critoph C; Green G; Hayes H; Baumwol J; Lam K; Larbalestier R; Chih S
    Artif Organs; 2016 Jan; 40(1):106-14. PubMed ID: 25994765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary artery pulsatility index predicts prolonged inotrope/pulmonary vasodilator use after implantation of continuous flow left ventricular assist device.
    Aggarwal V; Tume SC; Rodriguez M; Adachi I; Cabrera AG; Tunuguntla H; Qureshi AM
    Congenit Heart Dis; 2019 Nov; 14(6):1130-1137. PubMed ID: 31802608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of secondary pulmonary hypertension with bosentan after left ventricular assist device implantation.
    LaRue SJ; Garcia-Cortes R; Nassif ME; Vader JM; Ray S; Ravichandran A; Rasalingham R; Silvestry SC; Ewald GA; Wang IW; Schilling JD
    Cardiovasc Ther; 2015 Apr; 33(2):50-5. PubMed ID: 25759010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pulmonary vascular resistance before left ventricular assist device implantation on short- and long-term post-transplant survival.
    Tsukashita M; Takayama H; Takeda K; Han J; Colombo PC; Yuzefpolskaya M; Topkara VK; Garan AR; Mancini DM; Kurlansky PA; Naka Y
    J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1352-60, 1361.e1-2. PubMed ID: 26253875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled Pulmonary Vasodilator Therapy for Management of Right Ventricular Dysfunction after Left Ventricular Assist Device Placement and Cardiac Transplantation.
    Sabato LA; Salerno DM; Moretz JD; Jennings DL
    Pharmacotherapy; 2017 Aug; 37(8):944-955. PubMed ID: 28543813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraoperative Hemodynamic and Echocardiographic Measurements Associated With Severe Right Ventricular Failure After Left Ventricular Assist Device Implantation.
    Gudejko MD; Gebhardt BR; Zahedi F; Jain A; Breeze JL; Lawrence MR; Shernan SK; Kapur NK; Kiernan MS; Couper G; Cobey FC
    Anesth Analg; 2019 Jan; 128(1):25-32. PubMed ID: 29878942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance?
    Liden H; Haraldsson A; Ricksten SE; Kjellman U; Wiklund L
    Eur J Cardiothorac Surg; 2009 Jun; 35(6):1029-34; discussion 1034-5. PubMed ID: 19211259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of centrifugal left ventricular assist device as a bridge to candidacy in severe heart failure with secondary pulmonary hypertension.
    Kutty RS; Parameshwar J; Lewis C; Catarino PA; Sudarshan CD; Jenkins DP; Dunning JJ; Tsui SS
    Eur J Cardiothorac Surg; 2013 Jun; 43(6):1237-42. PubMed ID: 23345184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support.
    Tedford RJ; Hemnes AR; Russell SD; Wittstein IS; Mahmud M; Zaiman AL; Mathai SC; Thiemann DR; Hassoun PM; Girgis RE; Orens JB; Shah AS; Yuh D; Conte JV; Champion HC
    Circ Heart Fail; 2008 Nov; 1(4):213-9. PubMed ID: 19808294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intersection of Pulmonary Hypertension and Right Ventricular Dysfunction in Patients on Left Ventricular Assist Device Support: Is There a Role for Pulmonary Vasodilators?
    Sparrow CT; LaRue SJ; Schilling JD
    Circ Heart Fail; 2018 Jan; 11(1):e004255. PubMed ID: 29321132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left Ventricular Assist Devices or Inotropes for Decreasing Pulmonary Vascular Resistance in Patients with Pulmonary Hypertension Listed for Heart Transplantation.
    Al-Kindi SG; Farhoud M; Zacharias M; Ginwalla MB; ElAmm CA; Benatti RD; Oliveira GH
    J Card Fail; 2017 Mar; 23(3):209-215. PubMed ID: 27374840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of pulmonary hypertension with left heart disease: a concise review.
    Desai A; Desouza SA
    Vasc Health Risk Manag; 2017; 13():415-420. PubMed ID: 29158679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular assist device support of medically unresponsive pulmonary hypertension and aortic insufficiency.
    Adamson RM; Dembitsky WP; Jaski BE; Daily PO; Moreno R; Kim JC; Sono J; Akasaka T; Hoagland PM; Gordon JB
    ASAIO J; 1997; 43(4):365-9. PubMed ID: 9242955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diastolic Pulmonary Gradient as a Predictor of Right Ventricular Failure After Left Ventricular Assist Device Implantation.
    Alnsasra H; Asleh R; Schettle SD; Pereira NL; Frantz RP; Edwards BS; Clavell AL; Maltais S; Daly RC; Stulak JM; Rosenbaum AN; Behfar A; Kushwaha SS
    J Am Heart Assoc; 2019 Aug; 8(16):e012073. PubMed ID: 31411097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of continuous-flow ventricular assist device therapy with intensive medical therapy in fixed pulmonary hypertension secondary to advanced left heart failure.
    Kumarasinghe G; Jain P; Jabbour A; Lai J; Keogh AM; Kotlyar E; Jansz P; Macdonald PS; Hayward CS
    ESC Heart Fail; 2018 Aug; 5(4):695-702. PubMed ID: 29573567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporary right ventricular support following left ventricle assist device implantation: a comparison of two techniques.
    Noly PE; Kirsch M; Quessard A; Leger P; Pavie A; Amour J; Leprince P
    Interact Cardiovasc Thorac Surg; 2014 Jul; 19(1):49-55. PubMed ID: 24659551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cavoaortic shunt improves hemodynamics with preserved oxygen delivery in experimental right ventricular failure during left ventricular assist device therapy.
    Vikholm P; Schiller P; Johansson J; Hellgren L
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):625-31. PubMed ID: 23477692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of β-Blockers in Pulmonary Hypertension.
    Perros F; de Man FS; Bogaard HJ; Antigny F; Simonneau G; Bonnet S; Provencher S; Galiè N; Humbert M
    Circ Heart Fail; 2017 Apr; 10(4):. PubMed ID: 28364092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of Residual Mitral Regurgitation After Continuous Flow Left Ventricular Assist Device Implantation.
    Kassis H; Cherukuri K; Agarwal R; Kanwar M; Elapavaluru S; Sokos GG; Moraca RJ; Bailey SH; Murali S; Benza RL; Raina A
    JACC Heart Fail; 2017 Feb; 5(2):81-88. PubMed ID: 28017353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.